Global Newborn Genetic Screening Market Size, Share, Growth, Sale, Price, Insight, Analysis, Trend, Outlook & Forecast 2024-2030
Newborn Genetic Screening Market

Global Newborn Genetic Screening Market Size, Share, Growth, Sale, Price, Insight, Analysis, Trend, Outlook & Forecast 2024-2030

The Global "Newborn Genetic Screening Market" was valued at USD 1.42 Billion in 2023 and is projected to reach USD 2.14 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period (2024-2030). The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Get FREE Sample of this Report at https://shorturl.at/jGCnk

Newborn Genetic Screening Market

Newborn genetic screening is a medical test performed on newborns to detect genetic, metabolic, and other congenital disorders early in life. This helps in the timely treatment and management of conditions that might otherwise lead to severe health problems or developmental issues.

  • Influence of COVID-19: The impact of the COVID-19 pandemic has been considered in the estimation of market sizes, likely affecting supply chains, healthcare practices, and funding.
  • Impact of the Russia-Ukraine War: The ongoing conflict between Russia and Ukraine has also been factored into the market analysis, potentially influencing economic stability and international trade.
  • Drivers of Growth: Factors driving the market growth include increasing awareness about early detection of genetic disorders, technological advancements in genetic screening, and government initiatives for newborn health.
  • Technological Advancements: Innovations in genetic testing technologies, such as next-generation sequencing (NGS), are enhancing the accuracy and efficiency of newborn genetic screening.
  • Government Initiatives: Many countries have implemented mandatory newborn screening programs, which are expected to boost market growth.
  • Challenges: Challenges include high costs of advanced genetic tests, limited access to screening in low-income regions, and ethical concerns related to genetic testing.
  • Regional Insights: North America and Europe are expected to hold significant market shares due to established healthcare infrastructure and government support, while the Asia-Pacific region is projected to exhibit substantial growth owing to increasing healthcare investments and awareness.

The global key manufacturers of Newborn Genetic Screening include Trivitron Healthcare, MASIMO CORPORATION, Covidien Plc, Nemours KidsHealth, NJ.gov, Agilent Technologies, Ge Healthcare, PERKINELMER and Natus Medical Incorporated, etc. in 2023, the global top five players have a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Newborn Genetic Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn Genetic Screening. This report contains market size and forecasts of Newborn Genetic Screening in global, including the following market information:

  • Global Newborn Genetic Screening Market Revenue, 2019-2024, 2025-2030, ($ millions)
  • Global top five companies in 2023 (%)

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Newborn Genetic Screening companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Get FREE Sample of this Report at https://shorturl.at/jGCnk

Newborn Genetic Screening Market

Total Market by Segment:

Global Newborn Genetic Screening Market, by Type, 2019-2024, 2025-2030 ($ millions)

Global Newborn Genetic Screening Market Segment Percentages, by Type, 2023 (%)

  • Dry blood spot tests
  • Hearing screening tests
  • CCHD screening tests

Global Newborn Genetic Screening Market, by Application, 2019-2024, 2025-2030 ($ millions)

Global Newborn Genetic Screening Market Segment Percentages, by Application, 2023 (%)

  • Clinical Laboratories
  • Hospitals

Global Newborn Genetic Screening Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)

Global Newborn Genetic Screening Market Segment Percentages, By Region and Country, 2023 (%)

  • North America (United States, Canada, Mexico)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
  • The Middle East and Africa (Middle East, Africa)
  • South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Newborn Genetic Screening revenues in global market, 2019-2024 (estimated), ($ millions)
  • Key companies Newborn Genetic Screening revenues share in global market, 2023 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • Trivitron Healthcare
  • MASIMO CORPORATION
  • Covidien Plc
  • Nemours KidsHealth
  • NJ.gov
  • Agilent Technologies
  • Ge Healthcare
  • PERKINELMER
  • Natus Medical Incorporated
  • Waters
  • Bio-Rad Laboratories
  • Ab Sciex LLC

Get FREE Sample of this Report at https://shorturl.at/jGCnk

Outline of Major Chapters:

Chapter 1: Introduces the definition of Newborn Genetic Screening, market overview.

Chapter 2: Global Newborn Genetic Screening market size in revenue.

Chapter 3: Detailed analysis of Newborn Genetic Screening company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Newborn Genetic Screening in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: The main points and conclusions of the report.

Get FREE Sample of this Report at https://shorturl.at/jGCnk

CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170

Follow Us On linkedin :-https://www.dhirubhai.net/company/24-market-reports

要查看或添加评论,请登录

社区洞察

其他会员也浏览了